
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers

Tokyo
108-8384
Japan
Morinaga Milk Industry is one of Japan's leading dairy companies and a pioneer in microbiome science. Inspired by the discovery that bifidobacteria are the predominant bacteria in the intestines of breast-fed infants, Morinaga began its bifidobacteria research in the 1960s. In 1969, the company discovered its flagship strain, Bifidobacterium longum BB536, from a healthy breast-fed infant.
Today, backed by over 50 years of research, Morinaga proudly presents its HRB (Human-Residential Bifidobacteria) Probiotics portfolio, featuring BB536, M-16V, M-63, B-3, and MCC1274. These science-backed probiotics support a wide range of health areas, including gut health, infant nutrition, metabolism, cognition, healthy ageing, and more.
Complementing this portfolio, Morinaga's Postbiotics, LAC-Shield and LAC-Living+, provide innovative solutions for immune and mood support across a variety of applications and life stages. Together, our HRB Probiotics and Postbiotics deliver microbiome solutions that help support health and wellbeing from infancy through healthy ageing.
Upcoming webinars

The future of infant nutrition: From science to success
Valio

From tiny guts to big impact: the powerful potential of probiotics in children’s health
Novonesis

Inside GLP-1 lives: real consumer insights to inspire innovation
FrieslandCampina Ingredients











